Yuan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuan Li has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Lesley McGee
Division of Bacterial Disease, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta
10 shared publicationsZhongya Li
ASRT Inc
8 shared publicationsSopio Chochua
CDCP, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Resp Dis Branch, Atlanta, GA 30033 USA
7 shared publicationsBenjamin J. Metcalf
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
5 shared publicationsTheresa Tran
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
5 shared publicationsBernard Beall
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
4 shared publications
Latest Publications
- 27 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83  (2) , e300-e309
Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 U.S. States, 2004–2023
Background: Group A Streptococcus (GAS) infections are common in children, ranging from mild to life-threatening invasive disease. Large-scale descriptions of changes in pediatric invasive GAS infections in the United States, particularly during the COVID-19 pandemic, are limited. Methods: We used CDC’s Active Bacterial Core surveillance (ABCs), a multistate, population- and laboratory-based surveillance system, to assess changes in pediatric (<18 years old) invasive GAS incidence, clinical presentation, and bacterial strain characteristics from 2004–2023. Interrupted time series analysis was used to compare observed versus expected GAS incidence during 2020–2023, informed by trends before the COVID-19 pandemic (2004–2019). Results: During 2004–2023, 2,856 invasive GAS cases were identified. Incidence remained stable from 2004–2019 (mean incidence 1.9 per 100,000), decreased in 2020 (1.0) and 2021 (0.6), and rebounded in 2022 (1.5) and 2023 (4.4). ICU admission increased from 2011 to 2023; case fatality remained stable. Penicillin resistance was not detected. Clindamycin non-susceptibility doubled from 2011 (3.8%) to 2022 (7.5%), before slightly decreasing in 2023 (6.4%). Infections due to emm1, the most frequently identified emm type in children with severe disease, almost disappeared in 2021 but surged in late 2022. Conclusions: After remaining stable for more than a decade, pediatric invasive GAS incidence declined during the COVID-19 pandemic and rebounded in 2022, more than doubling 2004–2019 incidence in 2023. While case fatality remained low, ICU admissions increased over time, highlighting the need for effective preventive measures such as vaccines. Increasing clindamycin non-susceptibility bears continued monitoring.
- 27 April 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83  (2) , e300-e309
Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 U.S. States, 2004–2023
Background: Group A Streptococcus (GAS) infections are common in children, ranging from mild to life-threatening invasive disease. Large-scale descriptions of changes in pediatric invasive GAS infections in the United States, particularly during the COVID-19 pandemic, are limited. Methods: We used CDC’s Active Bacterial Core surveillance (ABCs), a multistate, population- and laboratory-based surveillance system, to assess changes in pediatric (<18 years old) invasive GAS incidence, clinical presentation, and bacterial strain characteristics from 2004–2023. Interrupted time series analysis was used to compare observed versus expected GAS incidence during 2020–2023, informed by trends before the COVID-19 pandemic (2004–2019). Results: During 2004–2023, 2,856 invasive GAS cases were identified. Incidence remained stable from 2004–2019 (mean incidence 1.9 per 100,000), decreased in 2020 (1.0) and 2021 (0.6), and rebounded in 2022 (1.5) and 2023 (4.4). ICU admission increased from 2011 to 2023; case fatality remained stable. Penicillin resistance was not detected. Clindamycin non-susceptibility doubled from 2011 (3.8%) to 2022 (7.5%), before slightly decreasing in 2023 (6.4%). Infections due to emm1, the most frequently identified emm type in children with severe disease, almost disappeared in 2021 but surged in late 2022. Conclusions: After remaining stable for more than a decade, pediatric invasive GAS incidence declined during the COVID-19 pandemic and rebounded in 2022, more than doubling 2004–2019 incidence in 2023. While case fatality remained low, ICU admissions increased over time, highlighting the need for effective preventive measures such as vaccines. Increasing clindamycin non-susceptibility bears continued monitoring.
- Open Access
- 29 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12  (1)
The rise and spread of invasive emm49 Streptococcus pyogenes in the USA
Background. The propensity of Streptococcus pyogenes (group A Streptococcus ) to invade normally sterile sites and cause invasive group A Streptococcus (iGAS) disease varies across strains, which are classified using the emm gene. Between 2015 and 2017, multistate iGAS surveillance identified an ~150-fold increase of one particular emm type, emm 49. This genomic epidemiological analysis aimed to identify bacterial, patient and societal factors associated with this expansion. Methods. We analysed 1322 emm 49 iGAS cases and the genome sequences of the clinical isolates acquired through the population-based Active Bacterial Core surveillance during 2015–2022. For each invasive case, we received both a cultured isolate and a standardized case report form that included basic demographic attributes and risk factors of infection. A phylogeographic analysis was performed to reconstruct the divergence times and spatial dispersal history within our emm 49 collection. Results. Compared to other emm types, emm 49 cases were more common in males (63.5% vs. 58.3%, P =0.0143), in people experiencing homelessness (34.0% vs. 17.5%, P P emm 49 emerged in the western USA. Conclusion. Our findings suggest that the current nationwide outbreak may have originated from the introduction of emm 49 into disadvantaged (homeless and/or injecting drug users) adult subpopulations. This study underscores how social marginalization and broader social determinants of health can shape iGAS strain epidemiology in the USA.
- 29 January 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12  (1)
Open AccessThe rise and spread of invasive emm49 Streptococcus pyogenes in the USA
Background. The propensity of Streptococcus pyogenes (group A Streptococcus ) to invade normally sterile sites and cause invasive group A Streptococcus (iGAS) disease varies across strains, which are classified using the emm gene. Between 2015 and 2017, multistate iGAS surveillance identified an ~150-fold increase of one particular emm type, emm 49. This genomic epidemiological analysis aimed to identify bacterial, patient and societal factors associated with this expansion. Methods. We analysed 1322 emm 49 iGAS cases and the genome sequences of the clinical isolates acquired through the population-based Active Bacterial Core surveillance during 2015–2022. For each invasive case, we received both a cultured isolate and a standardized case report form that included basic demographic attributes and risk factors of infection. A phylogeographic analysis was performed to reconstruct the divergence times and spatial dispersal history within our emm 49 collection. Results. Compared to other emm types, emm 49 cases were more common in males (63.5% vs. 58.3%, P =0.0143), in people experiencing homelessness (34.0% vs. 17.5%, P P emm 49 emerged in the western USA. Conclusion. Our findings suggest that the current nationwide outbreak may have originated from the introduction of emm 49 into disadvantaged (homeless and/or injecting drug users) adult subpopulations. This study underscores how social marginalization and broader social determinants of health can shape iGAS strain epidemiology in the USA.
- Open Access
- 14 January 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64  (1) , e0112625
Whole-genome sequencing-based pathogen characterization for streptococcal infection directly from positive blood culture samples
Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. Consequently, public health laboratories can benefit from assays that directly process blood culture samples without requiring submission of clinical isolates to determine additional pathogen features not identified by clinical tests, such as vaccine serotype and bacterial genomic relatedness, for surveillance and outbreak response purposes. In partnership with the Minnesota Active Bacterial Core surveillance (ABCs) site, we identified blood culture samples positive for ABCs streptococcal pathogens and characterized them by a direct whole-genome sequencing from blood culture (dWGS) assay. The dWGS results were compared with the results of a reference method (WGS of isolates from the same cultures) to evaluate concordance in pathogen features and genome assemblies. Of the 97 eligible blood culture samples, 83 (86%) passed dWGS quality control criteria and were subjected to a total of 655 dWGS-based tests, which yielded 651 (99.3%) evaluable results. The percent agreement with reference results was 100% (83/83) for M protein gene ( emm )/capsular types and 100% (81/81) for multilocus sequencing types. For genotypic antimicrobial susceptibility testing prediction, the percent prediction agreement was 100% (487/487), false resistant prediction rate was 0% (0/417), and the false susceptible prediction rate was 0% (0/66). Assemblies of pathogen genomes from the same patient differed by 1.08 ± 1.68 (mean ± SD) sites per genome. The dWGS assay can extract high-quality, important streptococcal strain characteristics directly from positive blood culture samples to support evolving public health needs. IMPORTANCE: Whole-genome sequencing (WGS) technologies have emerged as a transformative toolkit used by public health microbiology laboratories to detect and characterize pathogens. The surveillance of bacterial diseases often relies on clinical laboratories to submit pathogen isolates to regional or national public health laboratories, which have the capacity to routinely conduct WGS-based strain characterization. Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. The study evaluated a direct whole-genome sequencing from blood culture (dWGS) assay that directly processes blood culture samples. The dWGS assay recovered high quality, important streptococcal strain characteristics, including vaccine serotypes and whole-genome assemblies, without requiring submission of clinical isolates. Thus, the dWGS assay represents a promising tool for addressing the evolving needs of public health laboratories in the metagenomics era.
- 14 January 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64  (1) , e0112625
Open AccessWhole-genome sequencing-based pathogen characterization for streptococcal infection directly from positive blood culture samples
Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. Consequently, public health laboratories can benefit from assays that directly process blood culture samples without requiring submission of clinical isolates to determine additional pathogen features not identified by clinical tests, such as vaccine serotype and bacterial genomic relatedness, for surveillance and outbreak response purposes. In partnership with the Minnesota Active Bacterial Core surveillance (ABCs) site, we identified blood culture samples positive for ABCs streptococcal pathogens and characterized them by a direct whole-genome sequencing from blood culture (dWGS) assay. The dWGS results were compared with the results of a reference method (WGS of isolates from the same cultures) to evaluate concordance in pathogen features and genome assemblies. Of the 97 eligible blood culture samples, 83 (86%) passed dWGS quality control criteria and were subjected to a total of 655 dWGS-based tests, which yielded 651 (99.3%) evaluable results. The percent agreement with reference results was 100% (83/83) for M protein gene ( emm )/capsular types and 100% (81/81) for multilocus sequencing types. For genotypic antimicrobial susceptibility testing prediction, the percent prediction agreement was 100% (487/487), false resistant prediction rate was 0% (0/417), and the false susceptible prediction rate was 0% (0/66). Assemblies of pathogen genomes from the same patient differed by 1.08 ± 1.68 (mean ± SD) sites per genome. The dWGS assay can extract high-quality, important streptococcal strain characteristics directly from positive blood culture samples to support evolving public health needs. IMPORTANCE: Whole-genome sequencing (WGS) technologies have emerged as a transformative toolkit used by public health microbiology laboratories to detect and characterize pathogens. The surveillance of bacterial diseases often relies on clinical laboratories to submit pathogen isolates to regional or national public health laboratories, which have the capacity to routinely conduct WGS-based strain characterization. Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. The study evaluated a direct whole-genome sequencing from blood culture (dWGS) assay that directly processes blood culture samples. The dWGS assay recovered high quality, important streptococcal strain characteristics, including vaccine serotypes and whole-genome assemblies, without requiring submission of clinical isolates. Thus, the dWGS assay represents a promising tool for addressing the evolving needs of public health laboratories in the metagenomics era.
- Open Access
- 24 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16  (1) , 1-12
GPS Pipeline: portable, scalable genomic pipeline for Streptococcus pneumoniae surveillance from Global Pneumococcal Sequencing Project
Streptococcus pneumoniae (pneumococcus) is a major pathogen globally, responsible for an estimated one million deaths annually and contributing significantly to the global burden of antimicrobial resistance. Ongoing surveillance of its vaccine antigen (i.e. serotypes), antimicrobial resistance, and pneumococcal lineages is crucial for assessing the impact of vaccination programs and guiding future vaccine design. However, current bioinformatics tools have several limitations that prevent them from enabling comprehensive analysis that allows simultaneous, large-scale, and independent generation of these crucial data. Here, we present the GPS Pipeline that enables reliable extraction of public health information from pneumococcal genomes using in silico methods. It can accurately identify 102 of 107 known serotypes, recognise 1053 pneumococcal lineages, and predict susceptibilities to 19 common antibiotics. Built on Nextflow and utilising containerisation technology, the GPS Pipeline minimises software setup requirements and bioinformatics expertise while facilitating large-scale analysis of genomic data. The GPS Pipeline was applied and validated on 20,924 pneumococcal genomes worldwide, demonstrating its effectiveness in enhancing responsiveness in pneumococcal genomic surveillance.
- 24 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16  (1) , 1-12
Open AccessGPS Pipeline: portable, scalable genomic pipeline for Streptococcus pneumoniae surveillance from Global Pneumococcal Sequencing Project
Streptococcus pneumoniae (pneumococcus) is a major pathogen globally, responsible for an estimated one million deaths annually and contributing significantly to the global burden of antimicrobial resistance. Ongoing surveillance of its vaccine antigen (i.e. serotypes), antimicrobial resistance, and pneumococcal lineages is crucial for assessing the impact of vaccination programs and guiding future vaccine design. However, current bioinformatics tools have several limitations that prevent them from enabling comprehensive analysis that allows simultaneous, large-scale, and independent generation of these crucial data. Here, we present the GPS Pipeline that enables reliable extraction of public health information from pneumococcal genomes using in silico methods. It can accurately identify 102 of 107 known serotypes, recognise 1053 pneumococcal lineages, and predict susceptibilities to 19 common antibiotics. Built on Nextflow and utilising containerisation technology, the GPS Pipeline minimises software setup requirements and bioinformatics expertise while facilitating large-scale analysis of genomic data. The GPS Pipeline was applied and validated on 20,924 pneumococcal genomes worldwide, demonstrating its effectiveness in enhancing responsiveness in pneumococcal genomic surveillance.
- Open Access
- 15 October 2024
- Published by Elsevier in The Lancet Microbe
- Vol. 5  (12) , 100927
Genomic cluster formation among invasive group A streptococcal infections in the USA: a whole-genome sequencing and population-based surveillance study
- 15 October 2024
- Published by Elsevier in The Lancet Microbe
- Vol. 5  (12) , 100927
Open AccessGenomic cluster formation among invasive group A streptococcal infections in the USA: a whole-genome sequencing and population-based surveillance study
- Open Access
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15  (1) , 1-12
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Invasive pneumococcal disease (IPD) due to non-vaccine serotypes after the introduction of pneumococcal conjugate vaccines (PCV) remains a global concern. This study used pathogen genomics to evaluate changes in invasive pneumococcal lineages before, during and after vaccine introduction in South Africa. We included genomes (N = 3104) of IPD isolates from individuals aged <18 years (2005–20), spanning four periods: pre-PCV, PCV7, early-PCV13, and late-PCV13. Significant incidence reductions occurred among vaccine-type lineages in the late-PCV13 period compared to the pre-PCV period. However, some vaccine-type lineages continued to cause invasive disease and showed increasing effective population size trends in the post-PCV era. A significant increase in lineage diversity was observed from the PCV7 period to the early-PCV13 period (Simpson’s diversity index: 0.954, 95% confidence interval 0.948-0.961 vs 0.965, 0.962-0.969) supporting intervention-driven population structure perturbation. Increases in the prevalence of penicillin, erythromycin, and multidrug resistance were observed among non-vaccine serotypes in the late-PCV13 period compared to the pre-PCV period. In this work we highlight the importance of continued genomic surveillance to monitor disease-causing lineages post vaccination to support policy-making and future vaccine designs and considerations.
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15  (1) , 1-12
Open AccessImpact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Invasive pneumococcal disease (IPD) due to non-vaccine serotypes after the introduction of pneumococcal conjugate vaccines (PCV) remains a global concern. This study used pathogen genomics to evaluate changes in invasive pneumococcal lineages before, during and after vaccine introduction in South Africa. We included genomes (N = 3104) of IPD isolates from individuals aged <18 years (2005–20), spanning four periods: pre-PCV, PCV7, early-PCV13, and late-PCV13. Significant incidence reductions occurred among vaccine-type lineages in the late-PCV13 period compared to the pre-PCV period. However, some vaccine-type lineages continued to cause invasive disease and showed increasing effective population size trends in the post-PCV era. A significant increase in lineage diversity was observed from the PCV7 period to the early-PCV13 period (Simpson’s diversity index: 0.954, 95% confidence interval 0.948-0.961 vs 0.965, 0.962-0.969) supporting intervention-driven population structure perturbation. Increases in the prevalence of penicillin, erythromycin, and multidrug resistance were observed among non-vaccine serotypes in the late-PCV13 period compared to the pre-PCV period. In this work we highlight the importance of continued genomic surveillance to monitor disease-causing lineages post vaccination to support policy-making and future vaccine designs and considerations.
- Open Access
- 11 September 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231  (4) , 871-882
Increased Proportions of Invasive Pneumococcal Disease Cases Among Adults Experiencing Homelessness Sets the Stage for New Serotype 4 Capsular-Switch Recombinants
Background: The Centers for Disease Control and Prevention's Active Bacterial Core surveillance (ABCs) identified increased serotype 4 invasive pneumococcal disease (IPD), particularly among adults experiencing homelessness (AEH). Methods: We quantified increased proportions of IPD cases in AEH during 2016–2022. Employing genomic-based characterization of IPD isolates, we identified serotype-switch variants. Recombinational analyses were used to identify the genetic donor and recipient strain that generated a serotype 4 progeny strain. We performed phylogenetic analyses of the serotype 4 progeny and of the serotype 12F genetic recipient to determine genetic distances. Results: We identified a cluster of 30 highly related (0–21 nucleotide differences) IPD isolates recovered during 2022–2023, corresponding to a serotype 4 capsular-switch variant. This strain arose through a multifragment recombination event between serotype 4/ST10172 and serotype 12F/ST220 parental strains. Twenty-five of the 30 cases occurred in Oregon. Of 29 cases with known residence status, 16 occurred in AEH. Variant emergence coincided with a 2.6-fold increase (57 to 148) of cases caused by the serotype 4/ST10172 donor lineage in 2022 compared to 2019 and its first appearance in Oregon. Most serotypes showed sequential increases of AEH IPD/all IPD ratios during 2016–2022 (eg, for all serotypes combined, 247/2198, 11.2% during 2022 compared to 405/5317, 7.6% for 2018–2019, P < .001). Serotypes 4 and 12F each caused more IPD than any other serotype in AEH during 2020–2022 (207 combined case isolates accounting for 38% of all IPD in AEH). Conclusions: Expansion and increased transmission of serotypes 4 and 12F among adults potentially led to recent genesis of an impactful hybrid serotype-switch variant.
- 11 September 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231  (4) , 871-882
Open AccessIncreased Proportions of Invasive Pneumococcal Disease Cases Among Adults Experiencing Homelessness Sets the Stage for New Serotype 4 Capsular-Switch Recombinants
Background: The Centers for Disease Control and Prevention's Active Bacterial Core surveillance (ABCs) identified increased serotype 4 invasive pneumococcal disease (IPD), particularly among adults experiencing homelessness (AEH). Methods: We quantified increased proportions of IPD cases in AEH during 2016–2022. Employing genomic-based characterization of IPD isolates, we identified serotype-switch variants. Recombinational analyses were used to identify the genetic donor and recipient strain that generated a serotype 4 progeny strain. We performed phylogenetic analyses of the serotype 4 progeny and of the serotype 12F genetic recipient to determine genetic distances. Results: We identified a cluster of 30 highly related (0–21 nucleotide differences) IPD isolates recovered during 2022–2023, corresponding to a serotype 4 capsular-switch variant. This strain arose through a multifragment recombination event between serotype 4/ST10172 and serotype 12F/ST220 parental strains. Twenty-five of the 30 cases occurred in Oregon. Of 29 cases with known residence status, 16 occurred in AEH. Variant emergence coincided with a 2.6-fold increase (57 to 148) of cases caused by the serotype 4/ST10172 donor lineage in 2022 compared to 2019 and its first appearance in Oregon. Most serotypes showed sequential increases of AEH IPD/all IPD ratios during 2016–2022 (eg, for all serotypes combined, 247/2198, 11.2% during 2022 compared to 405/5317, 7.6% for 2018–2019, P < .001). Serotypes 4 and 12F each caused more IPD than any other serotype in AEH during 2020–2022 (207 combined case isolates accounting for 38% of all IPD in AEH). Conclusions: Expansion and increased transmission of serotypes 4 and 12F among adults potentially led to recent genesis of an impactful hybrid serotype-switch variant.
- Open Access
- 10 June 2022
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76  (3) , e1266-e1269
Continued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018–2019
We analyzed 9630 invasive GAS surveillance isolates in the USA. From 2015–2017 to 2018–2019, significant increases in erythromycin-nonsusceptibility (18% vs 25%) and clindamycin-nonsusceptibility (17% vs 24%) occurred, driven by rapid expansions of genomic subclones. Prevention and control of clustered infections appear key to containing antimicrobial resistance.
- 10 June 2022
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 76  (3) , e1266-e1269
Open AccessContinued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018–2019
We analyzed 9630 invasive GAS surveillance isolates in the USA. From 2015–2017 to 2018–2019, significant increases in erythromycin-nonsusceptibility (18% vs 25%) and clindamycin-nonsusceptibility (17% vs 24%) occurred, driven by rapid expansions of genomic subclones. Prevention and control of clustered infections appear key to containing antimicrobial resistance.
- Open Access
- 24 July 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 1547
Genomic Surveillance of Streptococcus pyogenes Strains Causing Invasive Disease, United States, 2016–2017
Background: Streptococcus pyogenes is a major cause of severe, invasive infections in humans. The bacterial pathogen harbors a wide array of virulence factors and exhibits high genomic diversity. Rapid changes of circulating strains in a community are common. Understanding the current prevalence and dynamics of S. pyogenes lineages could inform vaccine development and disease control strategies. Methods: We used whole-genome sequencing (WGS) to characterize all invasive S. pyogenes isolates obtained through the United States Center for Disease Control and Prevention’s Active Bacterial Core surveillance (ABCs) in 2016 and 2017. We determined the distribution of strain features, including emm type, antibiotic resistance determinants, and selected virulence factors. Changes in strain feature distribution between years 2016 and 2017 were evaluated. Phylogenetic analysis was used to identify expanding lineages within emm type. Results: Seventy-one emm types were identified from 3873 isolates characterized. The emm types targeted by a 30-valent M protein-based vaccine accounted for 3230 (89%) isolates. The relative frequencies of emm types collected during the 2 years were similar. While all isolates were penicillin-susceptible, erythromycin-resistant isolates increased from 273 (16% of 2016 isolates) to 432 (23% of 2017 isolates), mainly driven by increase of the erm-positive emm types 92 and 83. The prevalence of 24 virulence factors, including 11 streptococcal pyrogenic toxins, ranged from 6 to 90%. In each of three emm types (emm 49, 82, and 92), a subgroup of isolates significantly expanded between 2016 and 2017 compared to isolates outside of the subgroup (P-values < 0.0001). Specific genomic sequence changes were associated with these expanded lineages. Conclusions: While the overall population structure of invasive S. pyogenes isolates in the United States remained stable, some lineages, including several that were antibiotic-resistant, increased between 2016 and 2017. Continued genomic surveillance can help monitor and characterize bacterial features associated with emerging strains from invasive infections.
- 24 July 2020
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 1547
Open AccessGenomic Surveillance of Streptococcus pyogenes Strains Causing Invasive Disease, United States, 2016–2017
Background: Streptococcus pyogenes is a major cause of severe, invasive infections in humans. The bacterial pathogen harbors a wide array of virulence factors and exhibits high genomic diversity. Rapid changes of circulating strains in a community are common. Understanding the current prevalence and dynamics of S. pyogenes lineages could inform vaccine development and disease control strategies. Methods: We used whole-genome sequencing (WGS) to characterize all invasive S. pyogenes isolates obtained through the United States Center for Disease Control and Prevention’s Active Bacterial Core surveillance (ABCs) in 2016 and 2017. We determined the distribution of strain features, including emm type, antibiotic resistance determinants, and selected virulence factors. Changes in strain feature distribution between years 2016 and 2017 were evaluated. Phylogenetic analysis was used to identify expanding lineages within emm type. Results: Seventy-one emm types were identified from 3873 isolates characterized. The emm types targeted by a 30-valent M protein-based vaccine accounted for 3230 (89%) isolates. The relative frequencies of emm types collected during the 2 years were similar. While all isolates were penicillin-susceptible, erythromycin-resistant isolates increased from 273 (16% of 2016 isolates) to 432 (23% of 2017 isolates), mainly driven by increase of the erm-positive emm types 92 and 83. The prevalence of 24 virulence factors, including 11 streptococcal pyrogenic toxins, ranged from 6 to 90%. In each of three emm types (emm 49, 82, and 92), a subgroup of isolates significantly expanded between 2016 and 2017 compared to isolates outside of the subgroup (P-values < 0.0001). Specific genomic sequence changes were associated with these expanded lineages. Conclusions: While the overall population structure of invasive S. pyogenes isolates in the United States remained stable, some lineages, including several that were antibiotic-resistant, increased between 2016 and 2017. Continued genomic surveillance can help monitor and characterize bacterial features associated with emerging strains from invasive infections.
- 1 May 2020
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20  (5) , 538-539
M1UK lineage in invasive group A streptococcus isolates from the USA
- 1 May 2020
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20  (5) , 538-539
M1UK lineage in invasive group A streptococcus isolates from the USA